182 related articles for article (PubMed ID: 32583155)
1. Increased IL-10+CD206+CD14+M2-like macrophages in alveolar lavage fluid of patients with small cell lung cancer.
Hu X; Gu Y; Zhao S; Hua S; Jiang Y
Cancer Immunol Immunother; 2020 Dec; 69(12):2547-2560. PubMed ID: 32583155
[TBL] [Abstract][Full Text] [Related]
2. Analyzing the percentage of different PD-1
Hu X; Gu Y; Li D; Zhao S; Hua S; Jiang Y
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1074-1083. PubMed ID: 31381177
[TBL] [Abstract][Full Text] [Related]
3. Elevated Circulating CD4
Hu X; Gu Y; Zhao S; Hua S; Jiang Y
Cancer Biother Radiopharm; 2019 Jun; 34(5):325-333. PubMed ID: 30925076
[No Abstract] [Full Text] [Related]
4. Antibody combinations for optimized staining of macrophages in human lung tumours.
Frafjord A; Skarshaug R; Hammarström C; Stankovic B; Dorg LT; Aamodt H; Woldbaek PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
Scand J Immunol; 2020 Jul; 92(1):e12889. PubMed ID: 32299134
[TBL] [Abstract][Full Text] [Related]
5. Increased pro-angiogenic factors, infiltrating neutrophils and CD163(+) macrophages in bronchoalveolar lavage fluid from lung cancer patients.
Chen L; Li Q; Zhou XD; Shi Y; Yang L; Xu SL; Chen C; Cui YH; Zhang X; Bian XW
Int Immunopharmacol; 2014 May; 20(1):74-80. PubMed ID: 24598169
[TBL] [Abstract][Full Text] [Related]
6. Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer.
Rice SJ; Belani CP
PLoS One; 2021; 16(12):e0260988. PubMed ID: 34855926
[TBL] [Abstract][Full Text] [Related]
7. The Interleukin-33/ST2 Axis Enhances Lung-Resident CD14+ Monocyte Function in Patients with Non-Small Cell Lung Cancer.
Wang L; Mei X; Liu X; Guo L; Yang B; Chen R
Immunol Invest; 2023 Jan; 52(1):67-82. PubMed ID: 36218388
[TBL] [Abstract][Full Text] [Related]
8. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M
Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-7 promotes lung-resident CD14
Li S; Wang Z; Zhang G; Fu J; Zhang X
Int Immunopharmacol; 2019 Feb; 67():202-210. PubMed ID: 30557823
[TBL] [Abstract][Full Text] [Related]
10. CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer.
Feng PH; Lee KY; Chang YL; Chan YF; Kuo LW; Lin TY; Chung FT; Kuo CS; Yu CT; Lin SM; Wang CH; Chou CL; Huang CD; Kuo HP
Am J Respir Crit Care Med; 2012 Nov; 186(10):1025-36. PubMed ID: 22955317
[TBL] [Abstract][Full Text] [Related]
11. Circulating CD14
Hou J; Zhang M; Ding Y; Wang X; Li T; Gao P; Jiang Y
Mediators Inflamm; 2018; 2018():5270657. PubMed ID: 30034290
[TBL] [Abstract][Full Text] [Related]
12. Upregulated TIGIT
Lin F; Hu X; Zhang Y; Ye S; Gu Y; Yan B; Wang L; Jiang Y
Mol Immunol; 2022 Jul; 147():40-49. PubMed ID: 35504057
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage.
Koyama K; Kagamu H; Miura S; Hiura T; Miyabayashi T; Itoh R; Kuriyama H; Tanaka H; Tanaka J; Yoshizawa H; Nakata K; Gejyo F
Clin Cancer Res; 2008 Nov; 14(21):6770-9. PubMed ID: 18980970
[TBL] [Abstract][Full Text] [Related]
14. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors.
Zheng G; Ettinger DS; Maleki Z
Acta Cytol; 2013; 57(3):281-90. PubMed ID: 23635388
[TBL] [Abstract][Full Text] [Related]
15. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
[TBL] [Abstract][Full Text] [Related]
16. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
Liu CY; Wang YM; Wang CL; Feng PH; Ko HW; Liu YH; Wu YC; Chu Y; Chung FT; Kuo CH; Lee KY; Lin SM; Lin HC; Wang CH; Yu CT; Kuo HP
J Cancer Res Clin Oncol; 2010 Jan; 136(1):35-45. PubMed ID: 19572148
[TBL] [Abstract][Full Text] [Related]
17. Clinical Implications of Hepatocyte Growth Factor, Interleukin-20, and Interleukin-22 in Serum and Bronchoalveolar Fluid of Patients with Non-Small Cell Lung Cancer.
Naumnik W; Naumnik B; Niklińska W; Ossolińska M; Chyczewska E
Adv Exp Med Biol; 2016; 952():41-49. PubMed ID: 27573644
[TBL] [Abstract][Full Text] [Related]
18. Assessment of local cellular immunity in lung cancer by bronchoalveolar lavage.
Lorenz J; Müller-Quernheim J; Castillo-Höfer C; Doboszỳnska A; Ferlinz R
Klin Wochenschr; 1990 Jul; 68(14):728-34. PubMed ID: 1975283
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)].
Huang F; Wang XL; Geng Y; Li MX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):507-9. PubMed ID: 15989803
[TBL] [Abstract][Full Text] [Related]
20. Functionally impaired follicular helper T cells induce regulatory B cells and CD14
Qiu L; Yu Q; Zhou Y; Zheng S; Tao J; Jiang Q; Yuan G
Cancer Sci; 2018 Dec; 109(12):3751-3761. PubMed ID: 30325558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
